Home 2018-01-31T15:53:20+00:00

 

Consorzio per Valutazioni Biologiche e Farmacologiche (CVBF) is a not-for-profit organisation, founded in 2000 with the mission to perform research and provide scientific, economic and regulatory consultancy for innovation in the health sector at European level. The main fields of interest are life sciences and biotechnologies, drug development for small populations (pediatric and rare diseases), research management andmethodology, monitoring, statistics, regulatory, ethics and pharmacovigilance.

Who we are

Activities

Development and application of innovative methodologies in clinical trials for small populations, management of disease registries, execution of studies in the pharmacological field. Find out more.
Development and supervision of dossiers and documentation regarding national and European authorisation procedures for medicinal products. Find out more.
Development and management of all clinical trial phases, which are performed by the Consortium both as a Sponsor and as a Contract Research Organisation (CRO). Find out more.
Educational activities addressed to public bodies, research institutes and private companies, also within CME programmes. Find out more.
Management and participation to medical research projects and consortiums at national and international level. Find out more.
Design and management of registries and drug databases. Find out more.
Research networks aimed to facilitate transfer of know-how and to promote national and international research as well as scientific excellence. Find out more.
CVBF Brochure

On-going Projects

Slide background
Slide background
Slide background
Slide backgroundSlide thumbnail
Closed logo
logo innermed

Latest News

606, 2018

15-16th June 2018, 11th Edition of “Positive Psychology and interconnection: real and virtual communities” Days. A new opportunity to present KIDS Bari

The 11th edition of the “Positive Psychology and interconnection: real and virtual communities” Days will take place on 15th and 16th June, 2018 at the University of Bari, and it will be focused on the perspectives [...]

2905, 2018

Launch of a new public-private partnership to improve clinical trial infrastructure to facilitate the development of new drugs for children in Europe

The members of the “conect4children” (c4c) initiative today announced the start of a large collaborative paediatric network that will facilitate the development of new drugs and other therapies for the entire paediatric population in Europe. The [...]